OUR PRODUCTS

MOBILE APPS

GENERAL INFO

REGN

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Regeneron Pharmaceuticals (REGN) Earnings Date & Reports

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

REGN is expected to report earnings to fall 24.90% to $9.68 per share on October 30

Regeneron Pharmaceuticals REGN Stock Earnings Reports

Q3'25

Est.

$9.68

Q2'25

Beat

by $4.39

Q1'25

Missed

by $0.26

Q4'24

Beat

by $0.80

Q3'24

Beat

by $0.74

The last earnings report on August 01 showed earnings per share of $12.89, beating the estimate of $8.50. With 93.03K shares outstanding, the current market capitalization sits at 61.52B.

View a ticker or compare two or three

Compare

REGN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For REGN
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. REGN showed earnings on August 01, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of medicines for the treatment of serious medical conditions

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

777 Old Saw Mill River Road

Phone

+1 914 847-7000

Employees

13450

Web

https://www.regeneron.com